---
title: Wearable cues help walking timing
nct_id: NCT06430151
phase: NA
status: RECRUITING
sponsor: Dr Alistair Mackett
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06430151"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06430151"
last_fetched: "2026-05-10T14:02:37.516Z"
source: "Parkinson's Pathways (curated)"
---
# Wearable cues help walking timing

**Goal (in five words):** Wearable cues help walking timing

**Official Title:** Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease

**Trial ID:** [NCT06430151](https://clinicaltrials.gov/study/NCT06430151)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Dr Alistair Mackett
- **Target Enrollment:** 20 participants
- **Start Date:** 2024-05-16
- **Completion Date:** 2024-11-16
- **Conditions:** Parkinson Disease
- **Interventions:** CUE1
- **Intervention Types:** DEVICE

## Summary For Families

The goal is to find out whether older people with Parkinson's can comfortably use and accept the CUE1 wearable as a help for walking and movement timing. CUE1 is a small, chest-worn adhesive device that delivers gentle tactile cues to help time steps and posture; it is a non-drug, wearable aid so it would be used alongside levodopa rather than interacting with it. The focus is on real-world usability, comfort, and whether people are happy to wear it, not on testing a new medication. They are looking for 20 people aged 60 to 100 with a confirmed Parkinson's diagnosis under the Cambridge movement disorder service, excluding those with dementia or other major neurological diseases, atypical parkinsonism, implanted devices like pacemakers or DBS, chest trauma or adhesive sensitivity, severe mobility-limiting conditions, inability to consent, or current participation in another intervention trial.

## Eligibility

- **Minimum age:** 60 Years
- **Maximum age:** 100 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

1\. Individuals under the care of a Cambridge University Hospitals Foundation Trust movement disorder service with an established clinical diagnosis of Parkinson's disease based on the UK Brain bank criteria

Exclusion Criteria:

1. Co-existing significant neurological disorder (disabling stroke, multiple sclerosis, dementia, motor neurone disease),
2. Atypical parkinsonian disorder diagnosis (e.g. multiple systems atrophy, progressive supranuclear palsy or cortical basal degeneration syndrome)
3. co-existing physical impairment or disability causing significant mobility impairment (severe lower limb osteoarthritis)
4. trauma or pain to the sternum
5. use of other medical device e.g. pacemaker, deep brain stimulator, TENS machine etc
6. lacking capacity to consent to the study
7. Sensitivity to medical adhesives
8. Existing participant in intervention research trial
```

## Locations (1)

- Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom _(52.2000, 0.1167)_
  - Alistair J Mackett, MBBS — (CONTACT) — 01223 217483

## Central Contacts

- Alistair J Mackett, MBBS — (CONTACT) — 01223 217483 — alistair.mackett1@nhs.net

---

*Canonical: https://parkinsonspathways.com/trial/NCT06430151*  
*HTML version: https://parkinsonspathways.com/trial/NCT06430151*  
*Source data: https://clinicaltrials.gov/study/NCT06430151*